Kala Bio Inc. (NASDAQ: KALA) stock is down on Monday after the company halted development of its experimental treatment for a specific eye condition.
Why Is Eye Disease Focused Kala Bio Stock Plunging On Monday?
Where Today's News Shapes Tomorrow
